Powder: -20°C for 3 years
In solvent: -80°C for 2 years
1. Curculigoside can prevent bone loss , improve osteogenesis and inhibit osteoclastogenesis of hAFSCs, suggesting its potential use to regulate hAFSC osteogenic differentiation for treating bone disorders. 2. Curculigoside can promote calcium deposition and increase the levels of ALP and Runx2 in osteoblasts under oxidative stress via anti-oxidative character. 3. Curculigoside possesses potent antioxidant properties against oxidative stress insults. can protect endothelial cells against oxidative injury induced by H2O2, suggesting that this compound may constitute a promising intervention against cardiovascular disorders.
Description | 1. Curculigoside can prevent bone loss , improve osteogenesis and inhibit osteoclastogenesis of hAFSCs, suggesting its potential use to regulate hAFSC osteogenic differentiation for treating bone disorders. 2. Curculigoside can promote calcium deposition and increase the levels of ALP and Runx2 in osteoblasts under oxidative stress via anti-oxidative character. 3. Curculigoside possesses potent antioxidant properties against oxidative stress insults. can protect endothelial cells against oxidative injury induced by H2O2, suggesting that this compound may constitute a promising intervention against cardiovascular disorders. |
Synonyms | Curculigoside, Janus kinase, Curculigoside A, NF-κB, JAK, Nuclear factor-κB, Nuclear factor-kappaB, STAT, inhibit, Inhibitor |
Molecular Weight | 466.439 |
Formula | C22H26O11 |
CAS No. | 85643-19-2 |
Powder: -20°C for 3 years
In solvent: -80°C for 2 years
DMSO: 84 mg/mL(180.1 mM)
Ethanol: 84 mg/mL(180.1 mM)
Pyridine, Methanol, etc.: Soluble
( < 1 mg/ml refers to the product slightly soluble or insoluble )
You can also refer to dose conversion for different animals. More
bottom
Please see Inhibitor Handling Instructions for more frequently ask questions. Topics include: how to prepare stock solutions, how to store products, and cautions on cell-based assays & animal experiments, etc.